The Role of Wnt Signalling in Chronic Kidney Disease (CKD)

被引:24
|
作者
Malik, Soniya A. [1 ]
Modarage, Kavindiya [1 ]
Goggolidou, Paraskevi [1 ]
机构
[1] Univ Wolverhampton, Fac Sci & Engn, Dept Biomed Sci & Physiol, Wulfruna St, Wolverhampton WV1 1LY, England
关键词
Wnt signalling; polycystic kidney disease; nephronophthisis; beta-catenin; planar cell polarity signalling; PLANAR CELL POLARITY; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; MOLECULAR-CLONING; BETA-CATENIN; JOUBERT-SYNDROME; PROTEIN; URETERAL OBSTRUCTION; ABERRANT ACTIVATION; WIDE ASSOCIATION; GENE;
D O I
10.3390/genes11050496
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Chronic kidney disease (CKD) encompasses a group of diverse diseases that are associated with accumulating kidney damage and a decline in glomerular filtration rate (GFR). These conditions can be of an acquired or genetic nature and, in many cases, interactions between genetics and the environment also play a role in disease manifestation and severity. In this review, we focus on genetically inherited chronic kidney diseases and dissect the links between canonical and non-canonical Wnt signalling, and this umbrella of conditions that result in kidney damage. Most of the current evidence on the role of Wnt signalling in CKD is gathered from studies in polycystic kidney disease (PKD) and nephronophthisis (NPHP) and reveals the involvement of beta-catenin. Nevertheless, recent findings have also linked planar cell polarity (PCP) signalling to CKD, with further studies being required to fully understand the links and molecular mechanisms.
引用
收藏
页数:19
相关论文
共 50 条
  • [1] INFLAMMASOME SIGNALLING IN HUMAN HYPOXIC CHRONIC KIDNEY DISEASE (CKD)
    Giuliani, K. T. K.
    Grivei, A.
    Nag, P.
    Wang, X.
    Ungerer, J.
    Forbes, J. M.
    Healy, H.
    Kassianos, A. J.
    NEPHROLOGY, 2021, 26 : 18 - 18
  • [2] The role of statins in chronic kidney disease (CKD): Friend or foe?
    Kassimatis, Theodoros I.
    Konstantinopoulos, Panagiotis A.
    PHARMACOLOGY & THERAPEUTICS, 2009, 122 (03) : 312 - 323
  • [3] Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
    Yamada, Shunsuke
    Nakano, Toshiaki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2023, 30 (08) : 835 - 850
  • [4] Chronic kidney disease CKD is misunderstood
    de Takats, Dominic
    BRITISH MEDICAL JOURNAL, 2010, 341
  • [5] HYPOCITRATURIA IN CHRONIC KIDNEY DISEASE (CKD)
    D'Almeida, E. A.
    Carney, S. L.
    Jones, B. F.
    Gillies, A. H.
    Trevillian, P. R.
    Nanra, R. S.
    NEPHROLOGY, 2006, 11 : A12 - A12
  • [6] Hospitalization in chronic kidney disease (CKD).
    Mix, C
    St Peter, WL
    Ebben, J
    Kausz, A
    Xue, J
    Collins, AJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 617A - 618A
  • [7] Oxidative stress and the role of redox signalling in chronic kidney disease
    Kishi, Seiji
    Nagasu, Hajime
    Kidokoro, Kengo
    Kashihara, Naoki
    NATURE REVIEWS NEPHROLOGY, 2024, 20 (02) : 101 - 119
  • [8] Oxidative stress and the role of redox signalling in chronic kidney disease
    Seiji Kishi
    Hajime Nagasu
    Kengo Kidokoro
    Naoki Kashihara
    Nature Reviews Nephrology, 2024, 20 : 101 - 119
  • [9] IL-6 Signalling in Chronic Kidney Disease (CKD) and Peritoneal Dialysis (PD) Patients
    Opatrna, S.
    Lysak, D.
    Klaboch, J.
    Parker, C.
    Sefrna, F.
    Topley, N.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2008, 31 (06): : 385 - 385
  • [10] Awareness of chronic kidney disease (CKD) among CKD patients
    Alghamdi, Abdullah H.
    Alshehri, Abdulrahman S.
    Alaseri, Ahmed Z.
    Alqarni, Khalid S.
    Almutairi, Salman K.
    Alaryni, Abdullah A.
    Alshammari, Omar A.
    Alenazi, Hanadi H.
    Alenazi, Nshmiah S.
    Qutub, Rayan
    Alammari, Yousef
    Al-Harbi, Khalid
    Hakami, Osamah A.
    Bukhari, Abdullah
    MEDICAL SCIENCE, 2022, 26 (124)